McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a June 13, 2017 edition of Life Sciences Intellectual Property Review in an article entitled, “Disagreement on outcome of SCOTUS Amgen v Sandoz ruling.” The US Supreme Court’s decision in the Amgen and Sandoz clash, which was handed down yesterday, has sparked disagreement between lawyers on the consequences of the ruling. View the article